Inventor
HOSOE KAZUNORI
JP20 patents
⚠️ This page may combine multiple inventors who share the name “HOSOE KAZUNORI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KANEGAFUCHI CHEMICAL IND
9 patentsUS5089516AFeb 18, 1992
1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity
KANEGAFUCHI CHEMICAL IND58 citations95
US4971996ANov 20, 1990
Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors
KANEGAFUCHI CHEMICAL IND66 citations95
US4983602AJan 8, 1991
3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
KANEGAFUCHI CHEMICAL IND60 citations94
US4853403AAug 1, 1989
3-phenylthiomethylstyrene derivative, process for preparing the same, and antiallergic agent and tyrosinekinase inhibiting agent containing the same
KANEGAFUCHI CHEMICAL IND29 citations92
US5202341AApr 13, 1993
Hydroxystyrene compounds having tyrosine kinase inhibiting activity
KANEGAFUCHI CHEMICAL IND45 citations91
US4859661AAug 22, 1989
Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
KANEGAFUCHI CHEMICAL IND35 citations91
US4440784AApr 3, 1984
Anti-inflammatory, analgesic, and antipyretic pharmaceutical composition
KANEGAFUCHI CHEMICAL IND14 citations73
US4431656AFeb 14, 1984
3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
KANEGAFUCHI CHEMICAL IND13 citations73
US4965261AOct 23, 1990
Substituted benzoxazinorifamycin derivative and antibacterial agent containing the same
KANEGAFUCHI CHEMICAL IND15 citations70
KANEKA CORP
9 patentsUS7015252B2Mar 21, 2006
Compositions for lessening oxidative stress
KANEKA CORP27 citations92
US5981522ANov 9, 1999
Treatment of disease caused by infection of Helicobacter
KANEKA CORP36 citations90
US6486161B1Nov 26, 2002
Use of rifamycin derivative for treating mastitis in a domestic animal
KANEKA CORP19 citations89
US5786349AJul 28, 1998
Method for treating chlamydia infectious diseases by rifamycin derivative
KANEKA CORP40 citations88
US7829080B2Nov 9, 2010
Stabilization method of reduced coenzyme Q10
KANEKA CORP2 citations63
US7754205B2Jul 13, 2010
Composition for transmucosal administration containing conenzyme Q as the active ingredient
KANEKA CORP4 citations62
US7364751B2Apr 29, 2008
Stabilized compositions of aqueous reduced coenzyme Q solution
KANEKA CORP4 citations62
US6939897B2Sep 6, 2005
Method and composition for inhibiting arteriosclerosis
KANEKA CORP2 citations62
US6362169B1Mar 26, 2002
Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith
KANEKA CORP0 citations42